Search results for "47"

showing 10 items of 1382 documents

Thrombosis and thromboembolism related to COVID‐19: A clarion call for obtaining solid estimates from large‐scale multicenter data

2020

Abstract The clinical spectrum of coronavirus disease 2019 (COVID‐19) is wide, ranging from minor, nonspecific symptoms to severe pneumonia, acute respiratory distress syndrome, multiorgan involvement, and shock. In severe cases, the acute systemic inflammatory response, coagulation activation, and diffuse endothelial damage may, in combination with hypoxia, immobilization, and underlying risk factors, result in potentially life‐threatening venous and arterial thrombotic events. The first data from single‐center retrospective studies suggest that thrombotic events are a key aspect of COVID‐19‐associated morbidity and mortality. We have planned and will be launching the COvid REgistry on THR…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Hospitalized patientsvenous thromboembolism610 Medicine & healthAcute respiratory distressregistrymedicine.disease_causeSARS‐CoV‐2COVID‐19Internal medicineMedicineIn patientthrombosisCoronavirusCOVIDbusiness.industryForumlcsh:RC633-647.510031 Clinic for AngiologyRetrospective cohort studyHematologylcsh:Diseases of the blood and blood-forming organsHypoxia (medical)medicine.diseaseThrombosismedicine.symptombusinessResearch and Practice in Thrombosis and Haemostasis
researchProduct

CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL

2019

Thromboembolic and bleeding events pose a severe risk for patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Many factors can contribute to promoting the thrombotic event due to the interaction between platelets, leukocytes, and endothelium alterations. Moreover, a significant role can be played by cardiovascular risk factors (CV.R) such as cigarette smoking habits, hypertension, diabetes, obesity and dyslipidemia. In this study, we evaluated the impact that CV.R plays on thrombotic risk and survival in patients with PV and ET .

medicine.medical_specialtyEndotheliumGastroenterologySettore MED/15 - Malattie Del Sangue03 medical and health sciences0302 clinical medicinePolycythemia veraInternal medicineDiabetes mellitushemic and lymphatic diseasesmedicinePlateletEssential ThrombocythemiaPolycythemia VeraThrombotic riskEssential thrombocythemiabusiness.industrylcsh:RC633-647.5Hematologylcsh:Diseases of the blood and blood-forming organsmedicine.diseaseObesityPolycythemia vera Essential ThrombocytemiaInfectious Diseasesmedicine.anatomical_structure030220 oncology & carcinogenesisOriginal ArticlebusinessDyslipidemia030215 immunologyMediterranean Journal of Hematology and Infectious Diseases
researchProduct

Machine Perfusions in Liver Transplantation: The Evidence‐Based Position Paper of the Italian Society of Organ and Tissue Transplantation

2020

The use of machine perfusion (MP) in liver transplantation (LT) is spreading worldwide. However, its efficacy has not been demonstrated, and its proper clinical use has far to go to be widely implemented. The Società Italiana Trapianti d’Organo (SITO) promoted the development of an evidence-based position paper. A 3-step approach has been adopted to develop this position paper. First, SITO appointed a chair and a cochair who then assembled a working group with specific experience of MP in LT. The Guideline Development Group framed the clinical questions into a patient, intervention, control, and outcome (PICO) format, extracted and analyzed the available literature, ranked the quality of th…

medicine.medical_specialtyEvidence-based practice2747 TransplantationGRADE; donor after circulatory death; donor brain death; hypothermic machine; liver transplant; machine perfusion; normothermic machine; normothermic regional perfusion; position papermedicine.medical_treatmentDelphi methodMEDLINEhypothermic machine610 Medicine & healthdonor after circulatory deathliver perfusion machine030230 surgeryLiver transplantationnormothermic regional perfusionliver03 medical and health sciences0302 clinical medicinenormothermic machineHumansMedicineMedical physics10217 Clinic for Visceral and Transplantation SurgeryHumansItalyTransplantationMachine perfusionHepatologybusiness.industrymachine perfusionOrgan Preservationdonor brain deathperfusion machineInstitutional review boardLiver Transplantation2746 SurgeryPerfusionTransplantationliver transplantGRADEItalyPosition paper2721 Hepatology030211 gastroenterology & hepatologySurgerybusinessposition paperHumanLiver Transplantation
researchProduct

Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review.

2019

Abstract The objective of this scoping review is to summarize the current use of pharmacokinetics for tailoring prophylaxis in hemophilia patients switching between clotting factor products. Patients with hemophilia may require switching of clotting factor concentrates due to a variety of factors, but there have been perceived risks associated with switching, such as inhibitor development or suboptimal protection due to inadequate dosing while titrating treatment. Studies that look at patients switching from one clotting factor concentrate to another are categorized in terms of their primary and/or secondary objectives, notably biosimilarity and comparative pharmacokinetic studies and inhib…

medicine.medical_specialtyFactor concentrate610 Medicine & healthReview Article030204 cardiovascular system & hematologyHemophilia ADrug SubstitutionHemophilia BFactor IX03 medical and health sciencesDrug substitution0302 clinical medicinePharmacokineticsmedicineDosingIntensive care medicineFactor IXClotting factorOriginal Articles: Haemostasisfactor IXFactor VIIIlcsh:RC633-647.5business.industryDosing regimenlcsh:Diseases of the blood and blood-forming organsHematology3. Good healthOnline‐only Articlesfactor VIII3121 General medicine internal medicine and other clinical medicinedrug substitution10032 Clinic for Oncology and Hematologydrug substitution; factor IX; factor VIII; hemophilia A; hemophilia Bhemophilia Bhemophilia Abusiness030215 immunologymedicine.drug
researchProduct

The Impact of Narrow-band Imaging on the Pre- and Intra- operative Assessments of Neoplastic and Preneoplastic Laryngeal Lesions. A Systematic Review

2020

Abstract Introduction Narrow-band imaging is an endoscopic diagnostic tool that, focusing on superficial vascular changes, is useful to detect suspicious laryngeal lesions, enabling their complete excision with safe and tailored resection margins. Objectives To analyze the applications and benefits of narrow-band imaging in detecting premalignant and malignant laryngeal lesions through a comparison with white-light endoscopy. Data Synthesis A literature search was performed in the PubMed, Scopus and Web of Science databases using strict keywords. Then, two authors independently analyzed the articles, read the titles and abstracts, and read completely only the relevant studies according to c…

medicine.medical_specialtyIntra operativeLesion03 medical and health sciences0302 clinical medicinePositive predicative valuemedicine030223 otorhinolaryngologyLeukoplakiaNarrow-band imagingmedicine.diagnostic_testbusiness.industryRCancerlarynx cancermedicine.diseaseEndoscopySettore MED/31 - OtorinolaringoiatriaRF1-547OtorhinolaryngologyFeature (computer vision)030220 oncology & carcinogenesisMedicineSystematic ReviewRadiologymedicine.symptombusinessnarrow-band imagingearly diagnosis
researchProduct

Results of an Early Access Treatment Protocol of Daratumumab Monotherapy in Spanish Patients With Relapsed or Refractory Multiple Myeloma

2020

Daratumumab is a human CD38-targeted monoclonal antibody approved as monotherapy for heavily pretreated relapsed and refractory multiple myeloma. We report findings for the Spanish cohort of an open-label treatment protocol that provided early access to daratumumab monotherapy and collected safety and patient-reported outcomes data for patients with relapsed or refractory multiple myeloma. At 15 centers across Spain, intravenous daratumumab (16 mg/kg) was administered to 73 patients who had >= 3 prior lines of therapy, including a proteasome inhibitor and an immunomodulatory drug, or who were double refractory to both. The median duration of daratumumab treatment was 3.3 (range: 0.03-13.17)…

medicine.medical_specialtyLeukopenialcsh:RC633-647.5business.industryAnemiaDaratumumablcsh:Diseases of the blood and blood-forming organsHematologyNeutropeniamedicine.disease002ArticleClinical trialRefractoryInternal medicineProteasome inhibitormedicinemedicine.symptombusinessAdverse effectmedicine.drugHemaSphere
researchProduct

Canine fossa puncture in endoscopic sinus surgery: report of two cases

2017

Abstract Introduction Chronic rhinosinusitis with nasal polyposis is a common chronic disease that often affects maxillary sinus. Endoscopic sinus surgery is the most common procedure for treating the majority of maxillary sinus lesions. Objective To demonstrate the role of canine fossa puncture during endoscopic sinus surgery procedure in patients with severe maxillary sinus disease. Methods We present 2 cases where canine fossa puncture has been performed as method to obtain a complete access to the maxillary antrum. Results According our experience, 2 cases on 296 endoscopic sinus surgery (0.6%) where antrostomy and used of angled microdebrider were not sufficient, canine fossa puncture …

medicine.medical_specialtyMaxillary sinusChronic rhinosinusitissinusitisCanine fossa punctureMiddle meatal antrostomyPuncturesMaxillary antrumMaxillary sinusYoung Adult03 medical and health sciencesNasal Polyps0302 clinical medicineMaxillary sinusitisotorhinolaryngologic diseasesmedicineHumansIn patient030223 otorhinolaryngologyAgedMaxillary sinus sinusitis Maxillary sinusitisAlternative methodsAngled microdebriderbusiness.industryOtorhinolaryngology2734 Pathology and Forensic MedicineEndoscopylcsh:Otorhinolaryngologylcsh:RF1-547SurgeryEndoscopic sinus surgerymedicine.anatomical_structureChronic diseaseOtorhinolaryngologyCanine fossaAngled microdebrider; Canine fossa puncture; Maxillary sinusitis; Middle meatal antrostomy; Otorhinolaryngology2734 Pathology and Forensic MedicineChronic DiseaseFemaleTomography X-Ray Computedbusiness030217 neurology & neurosurgery
researchProduct

Raman Spectroscopy Technology to Monitor the Carotenoids in Skin of Thalassemia Patients: A Novel Non-Invasive Tool Relating Oxidative Stress with Ir…

2014

In this work we approach the relationship between redox state and iron overload by noninvasive instrumental techniques. Intracardiac, liver iron and liver fibrosis have been monitored in transfusion-dependent thalassemia patients by magnetic resonance imaging and hepatic transient elastography examinations. These measurements have been matched with a non-invasive, and yet unexplored in clinical practice, evaluation of body’s oxidative stress through measurement of antioxidant carotenoids in skin, by a spectroscopic method based on Raman technology (RRS). The global body’s antioxidant status results from a balance between the level of antioxidants in cells and body fluids, including blood, a…

medicine.medical_specialtyPathologyAntioxidantmedicine.medical_treatmentThalassemiathalassemia raman spectroscopy body antioxidant statusManagement of thalassemiamedicine.disease_causeGastroenterologySettore MED/15 - Malattie Del SangueSettore BIO/10 - BiochimicaInternal medicinemedicineDiseases of the blood and blood-forming organsAdverse effectRaman spectroscopy technology skin carotenoids thalassemia oxidative stress.Carotenoidchemistry.chemical_classificationChemistryfood and beveragesRaman spectroscopy technology; skin carotenoids; thalassemia; oxidative stressmedicine.diseaseBiomarker (medicine)RC633-647.5Transient elastographyOxidative stressThalassemia Reports; Volume 4; Issue 2; Pages: 1967
researchProduct

Influence of genetic polymorphisms and mutations in the cardiac pathology of iron overload in thalassemia and sickle cell anemia patients: a retrospe…

2012

Cardiac disease in thalassemia is determined by the accumulation of iron in the tissue. Genetic factors could influence the severity and the rapidity of the modifications of the cardiac tissue. Mutations or polymorphisms of genes have already been described as being implicated in cardiac disease. In particular, we studied the polymorphisms C1091T in the Connexin 37 gene (CX 37), 4G -668 5G in the Plasminogen Activator Inhibitor-1 gene (PAI 1) and 5A-1171 6A in the Stromelysin-1 gene (SL) in 193 randomly selected patients affected by hemoglobinopathies and 100 normal subjects randomly selected from the general population. A retrospective analysis based on history, clinical data and imaging s…

medicine.medical_specialtyPathologyHeart diseasebusiness.industryThalassemiaCardiac pathologyRetrospective cohort studymedicine.diseaseGastroenterologySickle cell anemiaInternal medicinemedicineDiseases of the blood and blood-forming organsRC633-647.5businessheart disease PAI-1 Stromelysin Connexin 37.heart disease PAI-1 stromelysin connexin 37.heart disease; PAI-1; stromelysin; connexin 37Thalassemia Reports
researchProduct

Benign intracranial hypertension associated to blood coagulation derangements

2006

Abstract Background Benign Intracranial Hypertension (BIH) may be caused, at least in part, by intracranial sinus thrombosis. Thrombosis is normally due to derangements in blood coagulation cascade which may predispose to abnormal clotting activation or deficiency in natural inhibitors' control. The aim of the study is to examine the strength of the association between risk factors for thrombosis and BIH. Patients and methods The incidence of prothrombotic abnormalities among a randomly investigated cohort of 17 patients with BIH, was compared with 51 healthy subjects matched for sex, age, body mass index, height and social background. Results The number of subjects with protein C deficienc…

medicine.medical_specialtyPathologymedicine.medical_treatmentGastroenterologysymbols.namesakeProtein C deficiencyIntracranial hypertension blood coagulation fibrinolysisInternal medicineFibrinolysismedicineFisher's exact testAngiologyHematologybiologylcsh:RC633-647.5business.industrylcsh:Diseases of the blood and blood-forming organsHematologymedicine.diseaseThrombosisMethylenetetrahydrofolate reductasesymbolsbiology.proteinOriginal Clinical InvestigationbusinessBody mass index
researchProduct